ICR's Cancer Early Detection program is focused on building early warning systems out of arrays of blood- and urine-based biomarkers from cancer patients and healthy controls, mostly stages zero, one and two. We're using machine learning to predict cancer signatures to enable early intervention when cancer is most treatable.
ICR is dedicated to solving some of the most difficult problems in aging and age-related disease, including cancer early detection and prevention.
ICR's Cancer Prevention science is centered on developing prophylactic cancer vaccines. We are hiring scientists with deep backgrounds in peptide-based vaccine development, cancer immunology and immuno-oncology.